Bank of New York Mellon’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-832
| Closed | -$12K | – | 4550 |
|
|
2022
Q2 | $12K | Sell |
832
-3
| -0.4% | -$43 | ﹤0.01% | 4535 |
|
|
2022
Q1 | $31K | Sell |
835
-7
| -0.8% | -$260 | ﹤0.01% | 4581 |
|
|
2021
Q4 | $48K | Hold |
842
| – | – | ﹤0.01% | 4505 |
|
|
2021
Q3 | $86K | Hold |
842
| – | – | ﹤0.01% | 4350 |
|
|
2021
Q2 | $83K | Sell |
842
-1,547
| -65% | -$152K | ﹤0.01% | 4243 |
|
|
2021
Q1 | $244K | Buy |
2,389
+872
| +57% | +$89.1K | ﹤0.01% | 3987 |
|
|
2020
Q4 | $149K | Buy |
1,517
+91
| +6% | +$8.94K | ﹤0.01% | 4027 |
|
|
2020
Q3 | $686K | Buy |
1,426
+102
| +8% | +$49.1K | ﹤0.01% | 3328 |
|
|
2020
Q2 | $1.03M | Sell |
1,324
-574
| -30% | -$445K | ﹤0.01% | 3098 |
|
|
2020
Q1 | $1.32M | Buy |
1,898
+1,070
| +129% | +$743K | ﹤0.01% | 2781 |
|
|
2019
Q4 | $760K | Buy |
+828
| New | +$760K | ﹤0.01% | 3368 |
|